- Corporate Officers - E
- Ehrlich Christopher B
Insider Trading History of Ehrlich Christopher B
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Ehrlich Christopher B since 2006.
This trader's CIK number is 1293973.
At the time of last reporting, Ehrlich Christopher B was the Interim Chairman and CEO of Cero Therapeutics Holdings, Inc.. (stock ticker symbol CERO).
Also see all insider trading activities at Cero Therapeutics Holdings, Inc..
Note that in the past
Ehrlich Christopher B also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Paratek Pharmaceuticals, Inc. (TSPT) by Ehrlich Christopher B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | TSPT | 732,076 | $4,963,439 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Biomimetic Therapeutics, Inc. (BMTI) by Ehrlich Christopher B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | BMTI | 941,177 | $8,000,004 | 0 | $0 | 0 | $0 |
| 2006 | BMTI | 1,250 | $10,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Effector Therapeutics, Inc. (EFTR) by Ehrlich Christopher B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | EFTR | 35,213 | $90,708 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cero Therapeutics Holdings, Inc. (CERO) by Ehrlich Christopher B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CERO | 0 | $0 | 0 | $0 | 5,312,983 | $0 |
Yearly summary of insider trading at Corgentech Inc (CGTK) by Ehrlich Christopher B
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | CGTK | 2,200 | $19,844 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Ehrlich Christopher B:
1. Paratek Pharmaceuticals, Inc. (TSPT)
2. Biomimetic Therapeutics, Inc. (BMTI)
3. Effector Therapeutics, Inc. (EFTR)
4. Cero Therapeutics Holdings, Inc. (CERO)
5. Corgentech Inc (CGTK)
Table 1. Insider trading of Paratek Pharmaceuticals, Inc. (TSPT) by Ehrlich Christopher B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-20 | TSPT | Buy | 514,848 | 6.58 | 3,390,274 |
| 2011-09-21 | TSPT | Buy | 217,228 | 7.24 | 1,573,165 |
Table 2. Insider trading of Biomimetic Therapeutics, Inc. (BMTI) by Ehrlich Christopher B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-04-07 | BMTI | Buy | 941,177 | 8.50 | 8,000,004 |
| 2006-05-15 | BMTI | Buy | 1,250 | 8.00 | 10,000 |
Table 3. Insider trading of Effector Therapeutics, Inc. (EFTR) by Ehrlich Christopher B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-10-04 | EFTR | Buy | 346 | .57 | 197 |
| 2022-09-26 | EFTR | Buy | 18,867 | .55 | 10,376 |
| 2022-02-18 | EFTR | Buy | 1,000 | 4.30 | 4,300 |
| 2022-02-14 | EFTR | Buy | 2,000 | 4.45 | 8,900 |
| 2022-02-08 | EFTR | Buy | 1,000 | 4.92 | 4,920 |
| 2022-02-09 | EFTR | Buy | 1,000 | 4.75 | 4,750 |
| 2022-02-03 | EFTR | Buy | 5,000 | 5.15 | 25,750 |
| 2022-02-04 | EFTR | Buy | 1,000 | 5.00 | 5,000 |
| 2022-01-27 | EFTR | Buy | 5,000 | 5.30 | 26,515 |
Table 4. Insider trading of Cero Therapeutics Holdings, Inc. (CERO) by Ehrlich Christopher B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-09-25 | CERO | Option Ex | 5,312,983 | .00 | 0 |
Table 5. Insider trading of Corgentech Inc (CGTK) by Ehrlich Christopher B
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-02-28 | CGTK | Buy | 2,200 | 9.02 | 19,844 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Ehrlich Christopher B
(Interim Chairman and CEO of Cero Therapeutics Holdings, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.